Pharvaris N.V.
PHVS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001830487
In the last 90 days, Pharvaris N.V. insiders filed 0 open-market purchases and 18 sales; 125 institutions reported holding it in 13F filings for Q2 2026, worth $2.23B in total; Viking Global Investors is the only superinvestor holding it.
Q4 2022 vs. Q3 2022
How the institutions holding Pharvaris N.V. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 21 | 25 | +4 |
| Shares | 22.3M | 21.3M | −1.01M (−4.5%) |
| Value | $173.6M | $239.6M | +$66.0M (+38.0%) |
New holders (9)
Institutions that held Pharvaris N.V. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Soleus Capital Management, L.P. | 310,000 | $3.49M | 0.50% |
| Sio Capital Management, LLC | 285,000 | $3.21M | 1.71% |
| Walleye Capital LLC | 151,329 | $1.70M | 0.04% |
| Silverarc Capital Management, LLC | 100,000 | $1.13M | 0.39% |
| Lynx1 Capital Management LP | 25,325 | $284.9K | 0.25% |
| Schonfeld Strategic Advisors LLC | 16,300 | $183.4K | 0.00% |
| Quantamental Technologies LLC | 12,900 | $145.1K | 0.07% |
| UBS Group AG | 2,800 | $31.5K | 0.00% |
| FNY Investment Advisers, LLC | 880 | $9.00K | 0.01% |
Sold out (5)
Institutions that held Pharvaris N.V. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 1,104,552 | $8.47M |
| Suvretta Capital Management, LLC | 746,965 | $5.73M |
| Eventide Asset Management, LLC | 450,251 | $3.62M |
| Pictet Asset Management SA | 399,875 | $3.21M |
| Goldman Sachs Group Inc | 56,606 | $434.0K |